Lipoly
Your Fat Loss Sprint Guide
GLP-1 medications suppress appetite. The Fat Loss Sprint teaches your body — and your behaviour — how to work without them.
Wilding et al. (2022) followed Wegovy participants after stopping the medication. Within one year, mean weight regain was 11.6% of initial body weight — approximately two-thirds of what had been lost. This is not a personal failure. It reflects the mechanism: GLP-1 medications suppress appetite hormonally. When the medication stops, the hormonal environment returns toward baseline.
The question is not whether some regain is likely — it is. The question is what you can do to minimise it and extend the fat loss window.
The FLS creates a deep caloric deficit through a structured protocol — not pharmaceutical appetite suppression. It trains the behaviours (protein targeting, strength training, structured meal tracking, supplement protocol) that work independently of medication.
The FLS can be used as a structured reset if weight begins to drift upward — a 14-day sprint to recapture the progress, followed by a Maintenance Phase that builds independent sustainable habits.
The 14-day mandatory Maintenance Phase after every sprint is designed to recalibrate appetite hormones, NEAT, and behavioural habits at a new set point — the same recovery challenge that GLP-1 withdrawal creates, but structured into the protocol rather than left unmanaged.
| GLP-1 Medication | Lipoly Fat Loss Sprint | |
|---|---|---|
| Appetite suppression | Hormonal (GLP-1 receptor) | Nutritional ketosis (endogenous) |
| Behavioural habit building | Not built in | Mandatory: daily tracking, training, supplementation |
| Post-protocol structure | None | 14-day Maintenance Phase |
| Independence from ongoing treatment | None | Complete — protocol ends, habits remain |
| Protein targeting | Not specified | 2.2–3.0 g/kg LBM — lean mass protective |
| Training | Not specified | 2x/week strength — required |
The mechanisms of GLP-1 weight loss and PSMF weight loss are different — but the physiological outcomes share important parallels:
Nackers et al. (2010) and Purcell et al. (2014) both confirm that what determines long-term weight maintenance is post-protocol behaviour — not the mechanism of loss. The sprint builds that behaviour explicitly.
Consult your doctor before stopping any GLP-1 medication. Lipoly does not replace prescribed treatment.
See your numbers
Sprint level, calculated macros, and a recommended duration — based on your body composition.
Free 7-day trial · No charge today · Cancel anytime